SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+9%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$189M
AUM Growth
+$189M
(+54%)
Cap. Flow
+$54.9M
Cap. Flow
% of AUM
29.07%
Top 10 Holdings %
Top 10 Hldgs %
83.98%
Holding
25
New
6
Increased
11
Reduced
1
Closed
7
Top Buys
| 1 |
AbbVie
ABBV
|
$24.3M |
| 2 |
Sanofi
SNY
|
$17.5M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$16.2M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$6.44M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$5.66M |
Top Sells
| 1 |
GSK
GSK
|
$15.2M |
| 2 |
Viatris
VTRS
|
$12.8M |
| 3 |
Novo Nordisk
NVO
|
$5.77M |
| 4 |
Cooper Companies
COO
|
$4.76M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$4.46M |
Sector Composition
| 1 | Healthcare | 82.73% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AbbVie
ABBV
$372B
| $24.3M | 12.89% | +473,700 | New | +$24.3M |
|
|
2
Sanofi
SNY
$121B
| $23.7M | 12.53% | 452,600 +335,600 | +287% | +$17.5M |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $23.3M | 12.32% | 440,400 +95,100 | +28% | +$5.03M |
|
|
MDVN
4
DELISTED
MEDIVATION, INC.
MDVN
| $16.2M | 8.56% | +251,100 | New | +$16.2M |
|
5
Amgen
AMGN
$155B
| $15.8M | 8.37% | 128,098 +44,298 | +53% | +$5.46M |
|
6
Community Health Systems
CYH
$387M
| $15.5M | 8.22% | 396,400 +102,800 | +35% | +$4.03M |
|
7
Orthofix Medical
OFIX
$592M
| $15M | 7.97% | 499,098 +18,298 | +4% | +$552K |
|
|
AGN
8
DELISTED
ALLERGAN INC
AGN
| $12.4M | 6.56% | 99,800 +51,900 | +108% | +$6.44M |
|
9
Cardinal Health
CAH
$35.5B
| $6.24M | 3.3% | 89,100 +19,700 | +28% | +$1.38M |
|
|
MGLN
10
DELISTED
Magellan Health Services, Inc.
MGLN
| $6.14M | 3.25% | 103,400 +41,300 | +67% | +$2.45M |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.66M | 3% | +89,100 | New | +$5.66M |
|
12
Enanta Pharmaceuticals
ENTA
$180M
| $5.64M | 2.99% | 141,128 -19,343 | -12% | -$774K |
|
13
Biogen
BIIB
$19.4B
| $5.57M | 2.95% | +18,200 | New | +$5.57M |
|
|
XNPT
14
DELISTED
XENOPORT, INC.
XNPT
| $4.07M | 2.16% | 787,600 +545,800 | +226% | +$2.82M |
|
|
KYTH
15
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $3.56M | 1.88% | 89,500 +10,500 | +13% | +$417K |
|
|
SGNT
16
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $3.16M | 1.68% | +135,400 | New | +$3.16M |
|
17
Rigel Pharmaceuticals
RIGL
$697M
| $1.64M | 0.87% | 421,400 +301,700 | +252% | +$1.17M |
|
|
FPRX
18
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $958K | 0.51% | +48,700 | New | +$958K |
|
|
19
Cooper Companies
COO
$13.4B
| – | – | -38,400 | Closed | -$4.76M |
|
20
Edwards Lifesciences
EW
$47.8B
| – | – | -40,700 | Closed | -$2.68M |
|
|
21
GSK
GSK
$79.9B
| – | – | -285,600 | Closed | -$15.2M |
|
|
22
Ironwood Pharmaceuticals
IRWD
$214M
| – | – | -384,200 | Closed | -$4.46M |
|
|
23
Novo Nordisk
NVO
$251B
| – | – | -31,200 | Closed | -$5.77M |
|
|
24
Viatris
VTRS
$12.3B
| – | – | -294,500 | Closed | -$12.8M |
|
|
AET
25
DELISTED
Aetna Inc
AET
| – | – | -26,300 | Closed | -$1.8M |
|